Cargando…
CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma
SIMPLE SUMMARY: There is an urgent need to find an effective therapeutic target for pancreatic cancer owing to late diagnosis, tumor metastasis, and current ineffective targeted drugs. We aimed to identified potential targets for the treatment of pancreatic cancer. In this study, the specific mechan...
Autores principales: | Gu, Jichun, Guo, Yujie, Du, Jiali, Kong, Lei, Deng, Junyuan, Tao, Baian, Li, Hengchao, Jin, Chen, Fu, Deliang, Li, Ji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657053/ https://www.ncbi.nlm.nih.gov/pubmed/36358852 http://dx.doi.org/10.3390/cancers14215434 |
Ejemplares similares
-
High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway
por: Deng, Junyuan, et al.
Publicado: (2022) -
The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular
por: Deng, Junyuan, et al.
Publicado: (2022) -
Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro
por: Kong, Lei, et al.
Publicado: (2022) -
Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
por: Du, Jiali, et al.
Publicado: (2020) -
The Role of Diabetes Mellitus in the Malignant Pancreatic Cyst Neoplasm Diagnosis and Prognosis
por: Deng, Junyuan, et al.
Publicado: (2022)